PALI
PALISADE BIO, INC.
Nasdaq Biological Products, (No Diagnostic Substances) Non-accelerated filer
Smaller reporting company

Key Financials

Net Income
$-16781000
↓ 16.2%
Operating Income
$-18056000
↓ 21.5%
Revenue
$0
↓ 100.0%
Total Liabilities
$5.0M
↑ 46.5%
Total Assets
$134.3M
↑ 1134.8%
EPS (Diluted)
$-0.30
↑ 97.1%
Shareholders' Equity
$129.4M
↑ 1626.9%
Cash & Equivalents
$133.4M
↑ 1258.2%

Recent SEC Filings

Form Type Filed Date Link
PRE 14A 4/17/2026 View on SEC
8-K 4/2/2026 View on SEC
10-K 3/20/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC
SCHEDULE 13G/A 2/17/2026 View on SEC
4 2/13/2026 View on SEC
4 2/13/2026 View on SEC
SCHEDULE 13G/A 2/13/2026 View on SEC

Company Information

Field Value
Ticker PALI
Company Name PALISADE BIO, INC.
CIK 1357459
Sector Biological Products, (No Diagnostic Substances)
Industry Non-accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (858) 704-4900